Stocks in Focus

Company Switches to ‘Quantum-Resistant Cryptography’ on Its Website… AXGATE Co., Ltd. Up 8% [Featured Stock]

Kwon Oh Seok
2026-06-23 09:24:39
[Edaily Reporter Kwon Oh Seok ] AXGATE Co., Ltd.(356680) The stock price is surging in early trading. It appears that buying interest is surging following news that the company has successfully migrated the communication segment of its website to a next-generation “post-quantum cryptography (PQC)” system.

According to MP Doctor on the 23rd, AXGATE Co., Ltd. is trading at 17,560 won as of 9:16 a.m., up 8.40% from the previous trading day.
Earlier today, the company issued a press release stating, “This transition is significant because it was achieved solely using ‘AXGATE SSL INSIDE,’ a traffic security device developed in-house by AXGATE Co., Ltd., without relying on global CDN (Content Delivery Network) services.”
This demonstrates the company’s proprietary technological capabilities, which can be directly applied to sectors such as government and public institutions, national defense, and finance—where it is difficult to utilize external services. Quantum-resistant cryptography is recognized as a secure encryption technology even in future quantum computing environments. It is a next-generation security technology that major countries, including the United States, are currently pushing to adopt.
AXGATE Co., Ltd. explained, “The implementation of this technology on our company’s website is a direct demonstration that quantum security is no longer merely a theoretical concept but a widely adopted technology that functions perfectly in real-world service environments.”

Economy

Corporation

IT·Science

Economy

[Credit Checkpoint] LG Uplus Reduces Debt, but Shorter Maturities Pose a 'Challenge'

“Credit Checkpoint” is a column that assesses the credit rating risks of companies preparing to issue corporate bonds by examining their financial structure and cash flow. It evaluates a company’s sho…
2026-10-12 15:41:04

Corporation

Olix Pharmaceuticals, Inc.’s Application for Phase 2a Trial of Age-Related Macular Degeneration Treatment in New Zealand Rejected… Seeking Reconsideration

Olix Pharmaceuticals, Inc.(226950) Development of “OLX10212,” a candidate drug for age-related macular degeneration, has hit a snag in its Phase 2a clinical trial in New Zealand. This follows a determ…
2026-10-12 15:55:03

IT·Science

"Cookie Run" to Be Adapted into a Hollywood Animated Film… Partners with "Big Shot Pictures"

Devsisters corporation(194480)is partnering with Hollywood production company Big Shot Pictures to adapt the “Cookie Run” intellectual property (IP) into a feature-length animated film. The two compan…
2026-10-12 15:55:18